The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | 1,734 | 35,000 | SH | SOLE | 0 | 35,000 | 0 | 0 | |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 795 | 25,000 | SH | SOLE | 0 | 25,000 | 0 | 0 | |
ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 2,045 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
ACCELERON PHARMA INC | COM | 00434H108 | 1,267 | 35,000 | SH | SOLE | 0 | 35,000 | 0 | 0 | |
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 1,058 | 150,000 | SH | SOLE | 0 | 150,000 | 0 | 0 | |
ADMA BIOLOGICS INC | COM | 000899104 | 1,086 | 150,000 | SH | SOLE | 0 | 150,000 | 0 | 0 | |
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 6,227 | 165,000 | SH | SOLE | 0 | 165,000 | 0 | 0 | |
AERIE PHARMACEUTICALS INC | PUT | 00771V958 | 2,453 | 65,000 | SH | Put | SOLE | 0 | 65,000 | 0 | 0 |
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 2,458 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 9,191 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
ALLSCRIPTS HEALTHCARE SOLUTN | COM | 01988P108 | 2,963 | 225,000 | SH | SOLE | 0 | 225,000 | 0 | 0 | |
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,083 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
AMGEN INC | COM | 031162100 | 9,175 | 55,000 | SH | SOLE | 0 | 55,000 | 0 | 0 | |
ANTHEM INC | COM | 036752103 | 3,133 | 25,000 | SH | SOLE | 0 | 25,000 | 0 | 0 | |
ARRAY BIOPHARMA INC | COM | 04269X105 | 1,350 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | 0 | |
BIOGEN INC | COM | 09062X103 | 6,261 | 20,000 | SH | SOLE | 0 | 20,000 | 0 | 0 | |
BIOGEN INC | CALL | 09062X903 | 7,826 | 25,000 | SH | Call | SOLE | 0 | 25,000 | 0 | 0 |
BIOSCRIP INC | COM | 09069N108 | 2,168 | 750,000 | SH | SOLE | 0 | 750,000 | 0 | 0 | |
BOSTON SCIENTIFIC CORP | COM | 101137107 | 1,190 | 50,000 | SH | SOLE | 0 | 50,000 | 0 | 0 | |
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 3,505 | 65,000 | SH | SOLE | 0 | 65,000 | 0 | 0 | |
CELGENE CORP | COM | 151020104 | 7,840 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
CELGENE CORP | CALL | 151020904 | 7,840 | 75,000 | SH | Call | SOLE | 0 | 75,000 | 0 | 0 |
CHEMOCENTRYX INC | COM | 16383L106 | 906 | 150,000 | SH | SOLE | 0 | 150,000 | 0 | 0 | |
CIGNA CORPORATION | CALL | 125509909 | 3,258 | 25,000 | SH | Call | SOLE | 0 | 25,000 | 0 | 0 |
CLOVIS ONCOLOGY INC | COM | 189464100 | 11,716 | 325,000 | SH | SOLE | 0 | 325,000 | 0 | 0 | |
DERMIRA INC | COM | 24983L104 | 5,073 | 150,000 | SH | SOLE | 0 | 150,000 | 0 | 0 | |
EPIZYME INC | COM | 29428V104 | 738 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 554 | 40,000 | SH | SOLE | 0 | 40,000 | 0 | 0 | |
ESPERION THERAPEUTICS INC NE | PUT | 29664W955 | 693 | 50,000 | SH | Put | SOLE | 0 | 50,000 | 0 | 0 |
EXELIXIS INC | COM | 30161Q104 | 4,477 | 350,000 | SH | SOLE | 0 | 350,000 | 0 | 0 | |
FIVE PRIME THERAPEUTICS INC | PUT | 33830X954 | 1,312 | 25,000 | SH | Put | SOLE | 0 | 25,000 | 0 | 0 |
FLAMEL TECHNOLOGIES SA | SPONSORED ADR | 338488109 | 2,480 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | 0 | |
GILEAD SCIENCES INC | COM | 375558103 | 4,747 | 60,000 | SH | SOLE | 0 | 60,000 | 0 | 0 | |
GILEAD SCIENCES INC | CALL | 375558903 | 1,187 | 15,000 | SH | Call | SOLE | 0 | 15,000 | 0 | 0 |
GLAUKOS CORP | COM | 377322102 | 4,529 | 120,000 | SH | SOLE | 0 | 120,000 | 0 | 0 | |
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 7,491 | 325,000 | SH | SOLE | 0 | 325,000 | 0 | 0 | |
GLOBAL BLOOD THERAPEUTICS IN | PUT | 37890U958 | 5,249 | 100,000 | SH | Put | SOLE | 0 | 100,000 | 0 | 0 |
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 2,655 | 20,000 | SH | SOLE | 0 | 20,000 | 0 | 0 | |
GW PHARMACEUTICALS PLC | CALL | 36197T903 | 3,318 | 25,000 | SH | Call | SOLE | 0 | 25,000 | 0 | 0 |
GW PHARMACEUTICALS PLC | PUT | 36197T953 | 8,627 | 65,000 | SH | Put | SOLE | 0 | 65,000 | 0 | 0 |
HEALTHWAYS INC | COM | 422245100 | 4,366 | 165,000 | SH | SOLE | 0 | 165,000 | 0 | 0 | |
IMMUNOMEDICS INC | COM | 452907108 | 975 | 300,000 | SH | SOLE | 0 | 300,000 | 0 | 0 | |
IMPAX LABORATORIES INC | COM | 45256B101 | 2,370 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
INTERSECT ENT INC | COM | 46071F103 | 1,426 | 90,000 | SH | SOLE | 0 | 90,000 | 0 | 0 | |
INVUITY INC | COM NEW | 46187J205 | 1,372 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
IONIS PHARMACEUTICALS INC | COM | 462222100 | 1,832 | 50,000 | SH | SOLE | 0 | 50,000 | 0 | 0 | |
K2M GROUP HLDGS INC | COM | 48273J107 | 2,934 | 165,000 | SH | SOLE | 0 | 165,000 | 0 | 0 | |
KITE PHARMA INC | COM | 49803L109 | 1,676 | 30,000 | SH | SOLE | 0 | 30,000 | 0 | 0 | |
LHC GROUP INC | COM | 50187A107 | 2,397 | 65,000 | SH | SOLE | 0 | 65,000 | 0 | 0 | |
LILLY ELI & CO | CALL | 532457908 | 6,020 | 75,000 | SH | Call | SOLE | 0 | 75,000 | 0 | 0 |
MACROGENICS INC | COM | 556099109 | 1,196 | 40,000 | SH | SOLE | 0 | 40,000 | 0 | 0 | |
MAZOR ROBOTICS LTD | SPONSORED ADS | 57886P103 | 5,174 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | 0 | |
MEDICINES CO | COM | 584688105 | 7,548 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | 0 | |
MEI PHARMA INC | COM NEW | 55279B202 | 528 | 300,000 | SH | SOLE | 0 | 300,000 | 0 | 0 | |
MERCK & CO INC | COM | 58933Y105 | 4,681 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
MERUS N V | COM | N5749R100 | 3,350 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | 0 | |
MINERVA NEUROSCIENCES INC | COM | 603380106 | 3,176 | 225,000 | SH | SOLE | 0 | 225,000 | 0 | 0 | |
NUVASIVE INC | COM | 670704105 | 6,666 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
ONCOMED PHARMACEUTICALS INC | COM | 68234X102 | 8,287 | 725,000 | SH | SOLE | 0 | 725,000 | 0 | 0 | |
ONCOMED PHARMACEUTICALS INC | CALL | 68234X902 | 572 | 50,000 | SH | Call | SOLE | 0 | 50,000 | 0 | 0 |
ONCOMED PHARMACEUTICALS INC | PUT | 68234X952 | 572 | 50,000 | SH | Put | SOLE | 0 | 50,000 | 0 | 0 |
OPHTHOTECH CORP | COM | 683745103 | 1,615 | 35,000 | SH | SOLE | 0 | 35,000 | 0 | 0 | |
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 1,344 | 150,000 | SH | SOLE | 0 | 150,000 | 0 | 0 | |
PACIRA PHARMACEUTICALS INC | COM | 695127100 | 2,567 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
PFIZER INC | COM | 717081103 | 8,468 | 250,000 | SH | SOLE | 0 | 250,000 | 0 | 0 | |
PHARMERICA CORP | COM | 71714F104 | 2,105 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
PHARMERICA CORP | PUT | 71714F954 | 1,404 | 50,000 | SH | Put | SOLE | 0 | 50,000 | 0 | 0 |
PRA HEALTH SCIENCES INC | COM | 69354M108 | 848 | 15,000 | SH | SOLE | 0 | 15,000 | 0 | 0 | |
RETROPHIN INC | COM | 761299106 | 2,238 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
SAREPTA THERAPEUTICS INC | COM | 803607100 | 1,535 | 25,000 | SH | SOLE | 0 | 25,000 | 0 | 0 | |
SCYNEXIS INC | COM | 811292101 | 484 | 125,000 | SH | SOLE | 0 | 125,000 | 0 | 0 | |
SPECTRANETICS CORP | COM | 84760C107 | 2,760 | 110,000 | SH | SOLE | 0 | 110,000 | 0 | 0 | |
SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 3,710 | 150,000 | SH | SOLE | 0 | 150,000 | 0 | 0 | |
TANDEM DIABETES CARE INC | COM | 875372104 | 1,417 | 185,000 | SH | SOLE | 0 | 185,000 | 0 | 0 | |
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 1,133 | 50,000 | SH | SOLE | 0 | 50,000 | 0 | 0 | |
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 14,188 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | 0 | |
ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 11,052 | 85,000 | SH | SOLE | 0 | 85,000 | 0 | 0 |